Naseem Zojwalla, Chief Medical Officer at Olema Pharmaceuticals, Inc. (OLMA), sold 439,018 shares at $28.04 ($12.3M) on 2025-12-22, disclosed to the SEC on 2025-12-23.
Open-market sale of $12.3M OLMA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.03 | 57,079 | $1.6M | 13.1% |
| 2 | $28.03 | 57,079 | $1.6M | 13.1% |
| 3 | $28.93 | 12,921 | $374K | 3.0% |
| 4 | $28.93 | 12,921 | $374K | 3.0% |
| 5 | $28.04 | 100,000 | $2.8M | 22.9% |
| 6 | $27.66 | 99,509 |
| $2.8M |
| 22.5% |
| 7 | $27.66 | 99,509 | $2.8M | 22.5% |
| Total | $27.92 avg | 439,018 | $12.3M | 100% |
| Filing → |